Bin Liu
Nanjing University of Chinese Medicine(CN)The University of Texas MD Anderson Cancer Center(US)The University of Texas MD Anderson Cancer Center(US)Minzu University of China(CN)Guangxi Medical University(CN)Chinese Academy of Sciences(CN)Changchun Institute of Applied Chemistry(CN)Tianjin Nankai Hospital(CN)Hunan Mawangdui Hospital(CN)Xinjiang Academy of Agricultural Sciences(CN)Xinjiang Academy of Animal Science(CN)Zhengzhou Fruit Research Institute(CN)Second Affiliated Hospital of Jilin University(CN)Nanjing Second Hospital(CN)Xinjiang Uygur Autonomous Region Education Department(CN)Wuxi People's Hospital(CN)Hunan Institute of Mental Health(CN)Hubei Cancer Hospital(CN)State Key Laboratory of Rare Earth Resources UtilizationHuazhong University of Science and Technology(CN)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Bone health and treatments, Salivary Gland Tumors Diagnosis and Treatment, Cancer-related molecular mechanisms research, RNA modifications and cancer
Most-Cited Works
- → Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy(2010)504 cited
- → Functional genetic analysis of mouse chromosome 11(2003)197 cited
- → Novel MYBL1 Gene Rearrangements with Recurrent MYBL1–NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations(2015)197 cited
- → A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon Versus Paclitaxel-Eluting Stent for the Treatment of Drug-Eluting Stent In-Stent Restenosis(2014)170 cited
- → Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII–p38MAPK–pS249/T252RB Pathway(2018)167 cited
- → Oncogenic KRAS Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis(2021)